Immunocore Holdings plc Balance Sheet
IMCR / Health Care|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Immunocore Holdings plc had $1.1B in total assets and $381M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $467.7M | $455.7M | $442.6M | $402.5M | - |
| Accounts Receivable | - | - | $52.1M | $33.6M | - |
| Inventory | $6.7M | $5.4M | $4.5M | $692.0K | - |
| Current Assets | $996.7M | $929.9M | $528.8M | $474.0M | - |
| PP&E (Net) | $11.5M | $10.1M | $9.2M | $7.8M | - |
| Total Assets | $1.1B | $1.0B | $597.0M | $526.8M | - |
| Current Liabilities | $246.7M | $212.2M | $139.0M | $100.8M | - |
| Shareholders' Equity | $381.0M | $360.7M | $368.8M | $338.9M | $233.7M |